BIOLASE Provides Update to Dental School Program

BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that the Company has recently signed agreements with an additional five dental schools and one teaching hospital for integrating Waterlase dentistry into its course curriculum.

These dental schools include: University of Alabama School of Dentistry at Birmingham, University of Southern California School of Dentistry, University of Mississippi School of Dentistry, Creighton University School of Dentistry and West Virginia University School of Dentistry. The Company also signed an agreement with the North Shore Long Island Jewish Health System, which is a resident teaching hospital program.

To date, the Company has placed Waterlase systems at 20 of the 55 dental schools in the United States. Currently, the Company is in contract negotiations with an additional 15 U.S. dental schools that it expects to finalize over the coming quarters.

"Introducing Waterlase dentistry into dental and post-graduate course curricula is a primary goal of our clinical education initiative," commented, Robert E. Grant, President and CEO. "We applaud these institutions for recognizing Waterlase technology as a valuable and necessary aspect of their educational discipline by training future dental professionals on the benefits of Waterlase dentistry. Our goal is to have Waterlase units in all 55 U.S. dental schools within the next three years."

According to Dental-Ed Marketing LLC, 74% of dentists are using the same products that they used in dental school, measured 5 years after graduation. Over their remaining career, a new dental school graduate will purchase three times the amount of dental products compared to a 53 year-old dentist, which is the average age of a dentist who visits a dental meeting.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (http://www.biolase.com) is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine. The Company's products incorporate patented and patent pending technologies focused on reducing pain and improving clinical results. Its primary product, the Waterlase® system, is one of the best selling dental laser systems. The Waterlase system uses a patented combination of water and laser to precisely cut hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue. The Company also offers the LaserSmile(TM) system, which uses a laser to perform soft tissue and cosmetic procedures, including tooth whitening.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Distributed by Market Wire